We are live on ! Find out more
SCM

Salem Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 8.82%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
-8.82%
3 Year Est. Return
+32.26%
5 Year Est. Return
+45.09%
10 Year Est. Return
–
AUM
$226M
AUM Growth
-$2.8M
Cap. Flow
-$13.2M
Cap. Flow %
-5.83%
Top 10 Hldgs %
34.37%
Holding
75
New
1
Increased
6
Reduced
43
Closed
3

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$235K
2
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$190K
3
DOV icon
Dover
DOV
+$47.2K
4
KMB icon
Kimberly-Clark
KMB
+$30.5K
5
PCL
PLUM CREEK TIMBER CO (REIT)
PCL
+$21.8K

Top Sells

Rank Stock Value
1
HRI icon
Herc Holdings
HRI
+$4.87M
2
B
Barrick Mining
B
+$527K
3
SLB icon
SLB Ltd
SLB
+$397K
4
APC
Anadarko Petroleum
APC
+$387K
5
OXY icon
Occidental Petroleum
OXY
+$385K

Sector Composition

Rank Sector Weight
1 Healthcare 24.25%
2 Energy 19.75%
3 Technology 15.04%
4 Industrials 12.39%
5 Consumer Staples 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
1
CVS Health
CVS
$124B
$9.16M 4.06%
121,504
-4,326
-3% -$327K
JNJ icon
2
Johnson & Johnson
JNJ
$663B
$8.59M 3.81%
82,065
-2,953
-3% -$298K
NVS icon
3
Novartis
NVS
$304B
$8.13M 3.61%
100,267
-2,684
-3% -$211K
UL icon
4
Unilever
UL
$138B
$8.11M 3.6%
159,045
-5,307
-3% -$266K
WY icon
5
Weyerhaeuser
WY
$16.6B
$7.6M 3.37%
229,582
-5,550
-2% -$168K
HON icon
6
Honeywell
HON
$66.4B
$7.37M 3.27%
88,201
-2,855
-3% -$239K
MRK icon
7
Merck
MRK
$371B
$7.28M 3.23%
131,795
-4,219
-3% -$230K
DVN icon
8
Devon Energy
DVN
$52.9B
$7.17M 3.18%
90,308
-3,135
-3% -$228K
SLB icon
9
SLB Ltd
SLB
$85.3B
$7.07M 3.13%
59,933
-3,855
-6% -$397K
MRO
10
DELISTED
Marathon Oil Corporation
MRO
$7.05M 3.13%
176,550
-7,225
-4% -$267K
DD
11
DELISTED
Du Pont De Nemours E I
DD
$6.88M 3.05%
110,775
-4,319
-4% -$278K
IP icon
12
International Paper
IP
$19.7B
$6.82M 3.02%
144,588
-1,986
-1% -$87.1K
DD icon
13
DuPont de Nemours
DD
$17.8B
$6.78M 3.01%
52,055
-2,626
-5% -$335K
GE icon
14
GE Aerospace
GE
$350B
$6.71M 2.98%
53,273
-1,391
-3% -$177K
MSFT icon
15
Microsoft
MSFT
$3.71T
$6.66M 2.95%
159,646
-6,600
-4% -$267K
PFE icon
16
Pfizer
PFE
$162B
$6.6M 2.93%
234,274
+8,253
+4% +$235K
GSK icon
17
GSK
GSK
$100B
$6.12M 2.71%
91,504
-3,036
-3% -$205K
PG icon
18
Procter & Gamble
PG
$340B
$6.04M 2.68%
76,885
-2,887
-4% -$233K
PCAR icon
19
PACCAR
PCAR
$65.6B
$6.03M 2.67%
143,868
-5,625
-4% -$240K
INTC icon
20
Intel
INTC
$506B
$5.77M 2.56%
186,720
-6,625
-3% -$182K
CSCO icon
21
Cisco
CSCO
$431B
$5.32M 2.36%
214,175
-6,975
-3% -$166K
OXY icon
22
Occidental Petroleum
OXY
$60B
$5.09M 2.26%
51,771
-4,092
-7% -$385K
HAL icon
23
Halliburton
HAL
$30.9B
$5.04M 2.24%
71,050
-4,900
-6% -$314K
APC
24
DELISTED
Anadarko Petroleum
APC
$4.97M 2.21%
45,425
-3,800
-8% -$387K
EMC
25
DELISTED
EMC CORPORATION
EMC
$4.72M 2.09%
179,085
-4,975
-3% -$131K
1
2 3

Similar funds

FFC
Fure Financial Corporation Bloomington, Minnesota $122M AUM 1.51% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
SP
StackLine Partners New York $134M AUM 35.15% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
HGM
Highside Global Management Dallas, Texas $136M AUM 36.73% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
RCM
Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return
DIV
DCM International VI Menlo Park, California $114M AUM 73.96% 1-Year Est. Return

Salem Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Salem Capital Management held 75 positions worth $226M, down 1.2% from $228M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Salem Capital Management withdrew a net $13.2M in Q2 2014, closing 3 positions and reducing 43 holdings. Its most notable exit was Herc Holdings, an estimated $4.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Energy and Technology.

Against the trend, Salem Capital Management opened a new position in Royal Dutch Shell PLC ADS Class A worth $200K.

  • Salem Capital Management's largest Q2 2014 buy was Royal Dutch Shell PLC ADS Class A: 2,605 shares worth $200K.
  • Salem Capital Management added most to Pfizer in Q2 2014, an estimated $235K increase.
  • Salem Capital Management's biggest Q2 2014 reduction was SLB Ltd, cutting an estimated $397K.
  • Salem Capital Management fully exited Herc Holdings in Q2 2014, selling an estimated $4.87M.
  • Salem Capital Management's ten largest holdings make up 34% of its $226M portfolio in Q2 2014.
  • Salem Capital Management opened 1 new position and closed 3 in Q2 2014.
  • Salem Capital Management's portfolio value fell 1.2% quarter-over-quarter to $226M.

Based on Salem Capital Management's 13F filing for Q2 2014, filed 17 Jul 2014.